Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEG vs Lactulose for Hepatic Encephalopathy
NCT04436601Phase 4Unknown
- Sponsor
- Aga Khan University
- Start
- Mar 2020
- Primary completion
- Dec 2023
- Modality
- Polymer-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 4 trial of polyethylene glycol in hepatic encephalopathy (HE), sponsored by Aga Khan University. Status: unknown.
02
Drugs
polyethylene glycol
03
Conditions
hepatic encephalopathy (HE)
Beyond the preview
Go deeper on NCT04436601.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04436601.